CD8A and cancer: The presentation of antigens on MHC class I molecules called cross‐presentation is an important step for induction of cancer immunity, because once the MHC class I‐antigen conjugate is recognized by CD8+ T cells, the CD8+ T cells differentiate into cytotoxic T lymphocytes that play a major role in antitumor activity 118, 119.